These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34928470)

  • 1. Psychometric properties of the Spanish version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30).
    Calderon C; Ferrando PJ; Lorenzo-Seva U; Ferreira E; Lee EM; Oporto-Alonso M; Obispo-Portero BM; Mihic-Góngora L; Rodríguez-González A; Jiménez-Fonseca P
    Qual Life Res; 2022 Jun; 31(6):1859-1869. PubMed ID: 34928470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the EORTC QLQ-C30 in Uganda.
    Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
    Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Azeri Version of European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30): Translation and Validation.
    Davudov MM; Harirchi I; Amiraliyev N; Mehtiyeva E; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):267-271. PubMed ID: 31983195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): validation study of the Thai version.
    Silpakit C; Sirilerttrakul S; Jirajarus M; Sirisinha T; Sirachainan E; Ratanatharathorn V
    Qual Life Res; 2006 Feb; 15(1):167-72. PubMed ID: 16411041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evaluation of the EORTC QLQ-C30 psychometric properties in a large Brazilian cancer patient cohort as a function of their educational status.
    Paiva CE; Carneseca EC; Barroso EM; de Camargos MG; Alfano AC; Rugno FC; Paiva BS
    Support Care Cancer; 2014 Aug; 22(8):2151-60. PubMed ID: 24652051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric Properties of the PDRQ-9 in Cancer Patients: Patient-Doctor Relationship Questionnaire.
    Calderón C; Lorenzo-Seva U; Ferrando PJ; Martínez-Cabañes R; Higuera O; Gómez D; Palacin-Lois M; Pacheco-Barcia V; Hernández R; Fernández-Andújar M; Ferreira E; Carmona-Bayonas A; Jiménez-Fonseca P
    Psicothema; 2021 May; 33(2):304-311. PubMed ID: 33879304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
    Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F
    Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties and factorial analysis of invariance of the Satisfaction with Life Scale (SWLS) in cancer patients.
    Lorenzo-Seva U; Calderon C; Ferrando PJ; Del Mar Muñoz M; Beato C; Ghanem I; Castelo B; Carmona-Bayonas A; Hernández R; Jiménez-Fonseca P
    Qual Life Res; 2019 May; 28(5):1255-1264. PubMed ID: 30644028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric Properties of the Fatigue Questionnaire EORTC QLQ-FA12 in a Sample of Female Cancer Patients.
    Kecke S; Ernst J; Einenkel J; Singer S; Hinz A
    J Pain Symptom Manage; 2017 Dec; 54(6):922-928. PubMed ID: 28807705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
    Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
    Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
    BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric properties of the EORTC Quality of Life Questionnaire in inpatient cancer rehabilitation in Germany.
    Dirmaier J; Zaun S; Koch U; Harfst T; Schulz H
    Palliat Support Care; 2004 Jun; 2(2):115-24. PubMed ID: 16594241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17.
    Yekaninejad MS; Pakpour AH; Tadakamadla J; Kumar S; Mosavi SH; Fridlund B; Bottomley A; Aaronson NK
    Support Care Cancer; 2015 May; 23(5):1215-24. PubMed ID: 25312650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EORTC information questionnaire, EORTC QLQ-INFO25. Validation study for Spanish patients.
    Arraras JI; Manterola A; Hernández B; Arias de la Vega F; Martínez M; Vila M; Eito C; Vera R; Domínguez MÁ
    Clin Transl Oncol; 2011 Jun; 13(6):401-10. PubMed ID: 21680301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-cultural application of the Korean version of the EORTC QLQ-ELD14 questionnaire for elderly patients with cancer.
    Goo AJ; Shin DW; Yang HK; Park JH; Kim SY; Shin JY; Kim YA; Kim C; Hong NS; Min YJ; Park K
    J Geriatr Oncol; 2017 Jul; 8(4):271-276. PubMed ID: 28377101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it useful to calculate sum scores of the quality of life questionnaire EORTC QLQ-C30?
    Hinz A; Einenkel J; Briest S; Stolzenburg JU; Papsdorf K; Singer S
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):677-83. PubMed ID: 22624663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimensionality and Measurement Invariance of the Italian Version of the EORTC QLQ-C30 in Postoperative Lung Cancer Patients.
    Marzorati C; Monzani D; Mazzocco K; Pavan F; Monturano M; Pravettoni G
    Front Psychol; 2019; 10():2147. PubMed ID: 31649573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
    Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.